Emergent BioSolutions (EBS) Common Equity (2010 - 2026)
Emergent BioSolutions (EBS) posted Common Equity of $313.2 million for Q3 2026, down 46.2% from $582.5 million a year earlier and down 8.3% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Emergent BioSolutions' Common Equity came in at $522.6 million, up 8.2% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' Common Equity was $482.8 million in FY2024 (-25.6%), $649.3 million in FY2023 (-53.2%), $1.39 billion in FY2022 (-13.9%) and $1.61 billion in FY2021 (+11.1%).
- The Q3 2026 figure stands as the lowest quarterly Common Equity in data going back to Q4 2010.
- On a year-over-year basis, Common Equity has declined in each of the last three quarters, with an average decline of 8.6% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q2 2025, with growth of 38.8%; the weakest was Q2 2024, with a decline of 59.7%.
- According to Business Quant data, Common Equity for the three prior quarters was $341.4 million (Q2 2026), $523.1 million (Q1 2026) and $522.6 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | 313.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 313.20 Mn |
| Jun 30, 2026 | 341.40 Mn |
| Mar 31, 2026 | 523.10 Mn |
| Dec 31, 2025 | 522.60 Mn |
| Sep 30, 2025 | 582.50 Mn |
| Jun 30, 2025 | 536.20 Mn |
| Mar 31, 2025 | 552.70 Mn |
| Dec 31, 2024 | 482.80 Mn |
| Sep 30, 2024 | 508.40 Mn |
| Jun 30, 2024 | 386.30 Mn |
| Mar 31, 2024 | 663.90 Mn |
| Dec 31, 2023 | 649.30 Mn |
| Sep 30, 2023 | 697.20 Mn |
| Jun 30, 2023 | 957.70 Mn |
| Mar 31, 2023 | 1.20 Bn |
| Dec 31, 2022 | 1.39 Bn |
| Sep 30, 2022 | 1.43 Bn |
| Jun 30, 2022 | 1.51 Bn |
| Mar 31, 2022 | 1.57 Bn |
| Dec 31, 2021 | 1.61 Bn |
API Access
Emergent BioSolutions Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();